openPR Logo
Press release

Favipiravir Market Size, Share | Trend 2030

01-30-2023 12:42 PM CET | Health & Medicine

Press release from: Ameco Research

Global Favipiravir Market size is expected to be worth roughly USD 246 Million by 2030, growing at a CAGR of more than 4.3% during the projected timeframe of 2022-2030, according to Ameco Research

The favipiravir market is expected to see significant growth in the coming years due to increasing demand for effective treatment options for COVID-19. As the pandemic continues to spread globally, the need for drugs like favipiravir to treat infected individuals is likely to increase. Additionally, research and development efforts to improve the efficacy and safety of favipiravir may also drive market growth. However, there is also a risk of market saturation if the pandemic is brought under control or if more effective treatments are developed.

Favipiravir is an antiviral medication that is used to treat influenza. It works by inhibiting the replication of the virus in infected cells. In recent times, it has been used as a treatment option for COVID-19, although its effectiveness in treating the disease is still being studied.

Request for a sample of this premium research report @ https://www.amecoresearch.com/sample/276773

Global Favipiravir Market Trends

The favipiravir market is driven by several factors, including the ongoing COVID-19 pandemic which increased the demand for effective treatment options, R&D efforts to improve the efficacy and safety of favipiravir as a treatment for COVID-19, the drug's effectiveness in treating influenza, and the increasing number of patents and FDA approvals for favipiravir. However, the market also faces some challenges such as the high cost of the drug, limited data on its long-term safety, and the risk of market saturation if the pandemic is brought under control or if more effective treatments are developed.

The market opportunities include the potential for favipiravir to be used as a prophylactic treatment to prevent the spread of COVID-19, the potential for it to be used in combination with other treatments for COVID-19, the potential for it to be used to treat other viral infections, and the increasing investment in research and development for COVID-19 treatments.

Increasing Number of Patents and FDA Approvals for Favipiravir Drive the Market Growth

The increasing number of patents and FDA approvals for favipiravir can drive market growth by providing exclusive rights to the patent holder to manufacture and sell the drug, which can help to increase the sales and revenue of the company. Obtaining patents also prevents other companies from producing generic versions of the drug, which can help to maintain the prices of the drug. This can attract more companies to invest in the market, leading to increased production and distribution of the drug, ultimately driving the favipiravir market size.

FDA approvals, on the other hand, are critical for the commercialization and distribution of drugs in the United States, and the approval is a sign of the drug's safety and efficacy, which can increase the confidence of healthcare professionals and patients in using the drug. This can increase the demand for favipiravir and ultimately drive the favipiravir market value. The approvals also open up new markets for the drug, as it can be sold in different countries and regions around the world, which can also drive the favipiravir market growth.

Favipiravir Market Companies

Some of the most notable worldwide favipiravir market players are ChemRar Group, Beximco Pharmaceuticals Limited, Cipla Limited, Glenmark Pharmaceuticals, Lasa Supergenerics Limited, Hisun Pharm, Medivector, Inc, Zhejiang Hisun Pharmaceutical Co., Ltd., Sihuan Pharmaceuticals, Fujifilm Toyama Chemical Co., Ltd, and Beacon Pharmaceuticals.

Favipiravir Market Segmentation

Ameco Research has fragmented the global favipiravir market by disease, and end-user. By disease, the industry is sub-divided into severe acute respiratory syndrome (SARS), influenza viruses, ebola, coronavirus (COVID-19), and others.

In term of sales channel, the market is classified into drug store, clinics, hospital, and others. According to the favipiravir market forecast, the clinics segment is predicted to grow extensively in the global market over the next few years.

To receive personalized service, please share your research needs here@ https://www.amecoresearch.com/enquiry-before-buy/276773

Favipiravir Market Regional Outlook

The global favipiravir market is divided into several geographical regions: North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. According to a favipiravir industry analysis, the Asia-Pacific region is expected to dominate the global market. This growth is due to the presence of a large patient population, increasing government initiatives to control the spread of COVID-19, and the availability of low-cost generic drugs. China and India are the major countries contributing to the growth of the market in the region. In addition, the increasing number of clinical trials in the region is also expected to drive market growth. The Asia-Pacific region has a high number of clinical trials being conducted for Favipiravir, which can help to improve its safety and efficacy, and ultimately drive the regional favipiravir market share.

North America and Europe are also expected to show significant growth in the favipiravir market due to the presence of a large patient population, high healthcare expenditure, and the availability of advanced healthcare facilities. The U.S. and Canada are the major countries contributing to the growth of the market in North America, while Germany, France, and the UK are the major countries contributing to the growth of the market in Europe.

Buy this premium research report - https://www.amecoresearch.com/buy/276773

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Favipiravir Market Size, Share | Trend 2030 here

News-ID: 2904386 • Views:

More Releases from Ameco Research

HPAPI Market Spending on Track for USD 21.5 . Billion by 2032, Up 8.2CAGR
Introduction: High Potent Active Pharmaceutical Ingredients (HPAPIs) Market are compounds characterized by their high biological activity, necessitating stringent handling and manufacturing controls to ensure safety and efficacy. Recent trends in the pharmaceutical industry have spotlighted two significant aspects: the integration of artificial intelligence (AI) in HPAPI development and the implementation of advanced containment technologies. Request a free sample of our research report @ https://www.amecoresearch.com/sample/276609 How is Artificial Intelligence Transforming HPAPI Development? The pharmaceutical
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAGR | Insights and Forecast Till 2032
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAG …
Introduction: The global neurodiagnostics market is experiencing robust growth, fueled by the increasing prevalence of neurological disorders and technological advancements in diagnostic procedures. Valued at USD 7.1 billion in 2021, the market is projected to reach USD 13.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. This rise underscores the growing importance of neurodiagnostic tools, which are essential in diagnosing and monitoring conditions
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective Solution for Modern Agriculture | Insights, Future Growth, and Opportunities
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective …
Introduction The global farm equipment rental market is experiencing a notable growth trajectory. In 2021, the market was valued at USD 53.5 billion and is forecasted to nearly double, reaching USD 98.4 billion by 2030. This growth, at a steady CAGR of 7.1%, underscores the increasing demand for accessible, affordable agricultural machinery, which allows farmers to rent equipment like tractors, harvesters, sprayers, and specialized machinery for short or long-term use. As
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% CAGR - Key Trends, Opportunities, and Forecast Insights
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% …
Introduction: The global functional apparel market is experiencing exponential growth, driven by increasing consumer demand for multi-purpose clothing that combines comfort, style, and utility. The market, which was valued at USD 372.4 billion in 2021, is projected to reach USD 691.2 billion by 2030, with a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030. This significant growth highlights the increasing adoption of functional apparel across industries such as

All 4 Releases


More Releases for Favipiravir

Favipiravir Market Size, Share and Growth Report, 2034
"The global favipiravir market is valued at approximately $1.2 billion in 2024, driven by increasing demand for antiviral treatments and the rising prevalence of viral infections. The market is projected to grow significantly during the forecast period from 2025 to 2034, with an estimated market value reaching around $3.6 billion by 2034. This growth corresponds to a compound annual growth rate (CAGR) of about 12% over the forecast period." Exactitude Consultancy.,
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
The global Favipiravir market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032. Favipiravir Market Overview Favipiravir, an antiviral medication initially developed for influenza, gained prominence during the COVID-19 pandemic due to its potential efficacy against the virus. The market's growth is driven by the increasing prevalence
Favipiravir Market Regulation Analysis Forecast till 2030
According to Ameco Research Favipiravir Market report, the analysts took this into account when estimating the Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Favipiravir Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Favipiravir Market trends, segmentation, key companies, SWOT, PORTER and PEST
Favipiravir Market: Innovations, Trends, and Challenges
Favipiravir, an antiviral medication renowned for its efficacy in combating influenza A and B viruses, stands at the forefront of the pharmaceutical sector's transformative journey. With a projected market value set to escalate from USD 170 million in 2021 to USD 246 million by 2030, the Favipiravir market represents a pivotal domain in addressing viral infections. This comprehensive analysis delves into the market's dynamics, shedding light on its growth trajectory,
Favipiravir Market Size, Share | Growth - 2030
Exclusive Report by Ameco Research: Favipiravir Market Size Projected to Reach USD 246 Billion by 2030, Growing at 4.30% CAGR Ameco Research is proud to announce the launch of its latest market research report, Favipiravir Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research reports to
Favipiravir Market Global Growth Opportunities and Market Scenario and Forecast …
The global Favipiravir Market" evaluation and insights 2021-2025 is a complete evaluation primarily based totally on in-intensity studies at the improvement environment, marketplace dynamics, opportunities, growth, insights, and rising technology of Favipiravir market. The examiner covers historic information from 2016 to 2021 in addition to predictions 2025, making it a precious useful resource for enterprise executives, rising technology, rising trends, proportion estimation, and nearby overview. By comparing the marketplace's segmentation,